Literature DB >> 17065182

Added value of a physician-and-nurse-directed heart failure clinic: results from the Deventer-Alkmaar heart failure study.

Pieta W F Bruggink-André de la Porte1, Dirk J A Lok, Dirk J van Veldhuisen, Jan van Wijngaarden, Jan H Cornel, Nicolaas P A Zuithoff, Erik Badings, Arno W Hoes.   

Abstract

AIM: To determine whether an intensive intervention at a heart failure (HF) clinic by a combination of a clinician and a cardiovascular nurse, both trained in HF, reduces the incidence of hospitalisation for worsening HF and/or all-cause mortality (primary end point) and improves functional status (including left ventricular ejection fraction, New York Heart Association (NYHA) class and quality of life) in patients with NYHA class III or IV.
SETTING: Two regional teaching hospitals in The Netherlands.
METHODS: 240 patients were randomly allocated to the 1-year intervention (n = 118) or usual care (n = 122). The intervention consisted of 9 scheduled patient contacts-at day 3 by telephone, and at weeks 1, 3, 5, 7 and at months 3, 6, 9 and 12 by a visit-to a combined, intensive physician-and-nurse-directed HF outpatient clinic, starting within a week after hospital discharge from the hospital or referral from the outpatient clinic. Verbal and written comprehensive education, optimisation of treatment, easy access to the clinic, recommendations for exercise and rest, and advice for symptom monitoring and self-care were provided. Usual care included outpatient visits initialized by individual cardiologists in the cardiology departments involved and applying the guidelines of the European Society of Cardiology.
RESULTS: During the 12-month study period, the number of admissions for worsening HF and/or all-cause deaths in the intervention group was lower than in the control group (23 vs 47; relative risk (RR) 0.49; 95% confidence interval (CI) 0.30 to 0.81; p = 0.001). There was an improvement in left ventricular ejection fraction (LVEF) in the intervention group (plus 2.6%) compared with the usual care group (minus 3.1%; p = 0.004). Patients in the intervention group were hospitalised for a total of 359 days compared with 644 days for those in the usual care group. Beneficial effects were also observed on NYHA classification, prescription of spironolactone, maximally reached dose of beta-blockers, quality of life, self-care behaviour and healthcare costs.
CONCLUSION: A heart failure clinic involving an intensive intervention by both a clinician and a cardiovascular nurse substantially reduces hospitalisations for worsening HF and/or all-cause mortality and improves functional status, while decreasing healthcare costs, even in a country with a primary-care-based healthcare system.

Entities:  

Mesh:

Year:  2006        PMID: 17065182      PMCID: PMC1994472          DOI: 10.1136/hrt.2006.095810

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  32 in total

1.  Development and testing of the European Heart Failure Self-Care Behaviour Scale.

Authors:  T Jaarsma; A Strömberg; J Mårtensson; K Dracup
Journal:  Eur J Heart Fail       Date:  2003-06       Impact factor: 15.534

2.  A randomized trial of the efficacy of multidisciplinary care in heart failure outpatients at high risk of hospital readmission.

Authors:  Edward K Kasper; Gary Gerstenblith; Gail Hefter; Elizabeth Van Anden; Jeffrey A Brinker; David R Thiemann; Michael Terrin; Sandra Forman; Sheldon H Gottlieb
Journal:  J Am Coll Cardiol       Date:  2002-02-06       Impact factor: 24.094

Review 3.  Heart failure programmes in countries with a primary care-based health care system. Are additional trials necessary? Design of the DEAL-HF study.

Authors:  Pieta W F Bruggink-André de la Porte; Dirk J A Lok; Jan van Wijngaarden; Jan H Cornel; Dian Pruijsers-Lamers; Dirk J van Veldhuisen; Arno W Hoes
Journal:  Eur J Heart Fail       Date:  2005-08       Impact factor: 15.534

4.  Cost/utility ratio in chronic heart failure: comparison between heart failure management program delivered by day-hospital and usual care.

Authors:  Soccorso Capomolla; Oreste Febo; Monica Ceresa; Angelo Caporotondi; Giampaolo Guazzotti; Maria La Rovere; Marina Ferrari; Francesca Lenta; Sonia Baldin; Chiara Vaccarini; Marco Gnemmi; GianDomenico Pinna; Roberto Maestri; Paola Abelli; Sandro Verdirosi; Franco Cobelli
Journal:  J Am Coll Cardiol       Date:  2002-10-02       Impact factor: 24.094

5.  Randomized, controlled trial of integrated heart failure management: The Auckland Heart Failure Management Study.

Authors:  R N Doughty; S P Wright; A Pearl; H J Walsh; S Muncaster; G A Whalley; G Gamble; N Sharpe
Journal:  Eur Heart J       Date:  2002-01       Impact factor: 29.983

6.  Randomised controlled trial of specialist nurse intervention in heart failure.

Authors:  L Blue; E Lang; J J McMurray; A P Davie; T A McDonagh; D R Murdoch; M C Petrie; E Connolly; J Norrie; C E Round; I Ford; C E Morrison
Journal:  BMJ       Date:  2001-09-29

7.  Heart failure management: multidisciplinary care has intrinsic benefit above the optimization of medical care.

Authors:  Kenneth McDonald; Mark Ledwidge; John Cahill; Peter Quigley; Brian Maurer; Bronagh Travers; Mary Ryder; Emma Kieran; Lorna Timmons; Enda Ryan
Journal:  J Card Fail       Date:  2002-06       Impact factor: 5.712

8.  Nurse-led heart failure clinics improve survival and self-care behaviour in patients with heart failure: results from a prospective, randomised trial.

Authors:  A Strömberg; J Mårtensson; B Fridlund; L-A Levin; Jan-Erik Karlsson; U Dahlström
Journal:  Eur Heart J       Date:  2003-06       Impact factor: 29.983

9.  Home-based intervention in congestive heart failure: long-term implications on readmission and survival.

Authors:  Simon Stewart; John D Horowitz
Journal:  Circulation       Date:  2002-06-18       Impact factor: 29.690

10.  Differences between general practitioners and cardiologists in diagnosis and management of heart failure: a survey in every-day practice.

Authors:  Frans H Rutten; Diederick E Grobbee; Arno W Hoes
Journal:  Eur J Heart Fail       Date:  2003-06       Impact factor: 15.534

View more
  26 in total

1.  Improving guideline adherence in the treatment of atrial fibrillation by implementing an integrated chronic care program.

Authors:  J L M Hendriks; R Nieuwlaat; H J M Vrijhoef; R de Wit; H J G M Crijns; R G Tieleman
Journal:  Neth Heart J       Date:  2010-10       Impact factor: 2.380

2.  A nurse-led intervention for identification of drug-related problems.

Authors:  Monica Bergqvist; Johanna Ulfvarson; Eva Andersen Karlsson; Christer von Bahr
Journal:  Eur J Clin Pharmacol       Date:  2008-01-19       Impact factor: 2.953

Review 3.  The 2010 Canadian Cardiovascular Society guidelines for the diagnosis and management of heart failure update: Heart failure in ethnic minority populations, heart failure and pregnancy, disease management, and quality improvement/assurance programs.

Authors:  Jonathan G Howlett; Robert S McKelvie; Jeannine Costigan; Anique Ducharme; Estrellita Estrella-Holder; Justin A Ezekowitz; Nadia Giannetti; Haissam Haddad; George A Heckman; Anthony M Herd; Debra Isaac; Simon Kouz; Kori Leblanc; Peter Liu; Elizabeth Mann; Gordon W Moe; Eileen O'Meara; Miroslav Rajda; Samuel Siu; Paul Stolee; Elizabeth Swiggum; Shelley Zeiroth
Journal:  Can J Cardiol       Date:  2010-04       Impact factor: 5.223

Review 4.  Non-medical prescribing versus medical prescribing for acute and chronic disease management in primary and secondary care.

Authors:  Greg Weeks; Johnson George; Katie Maclure; Derek Stewart
Journal:  Cochrane Database Syst Rev       Date:  2016-11-22

5.  Do Self-Management Interventions Work in Patients With Heart Failure? An Individual Patient Data Meta-Analysis.

Authors:  Nini H Jonkman; Heleen Westland; Rolf H H Groenwold; Susanna Ågren; Felipe Atienza; Lynda Blue; Pieta W F Bruggink-André de la Porte; Darren A DeWalt; Paul L Hebert; Michele Heisler; Tiny Jaarsma; Gertrudis I J M Kempen; Marcia E Leventhal; Dirk J A Lok; Jan Mårtensson; Javier Muñiz; Haruka Otsu; Frank Peters-Klimm; Michael W Rich; Barbara Riegel; Anna Strömberg; Ross T Tsuyuki; Dirk J van Veldhuisen; Jaap C A Trappenburg; Marieke J Schuurmans; Arno W Hoes
Journal:  Circulation       Date:  2016-02-12       Impact factor: 29.690

6.  Effect of educational program on quality of life of patients with heart failure: a randomized clinical trial.

Authors:  Sima Lakdizaji; Hadi Hassankhni; Alireza Mohajjel Agdam; Mohammad Khajegodary; Rezvanieh Salehi
Journal:  J Caring Sci       Date:  2013-02-26

7.  Case management for patients with chronic systolic heart failure in primary care: the HICMan exploratory randomised controlled trial.

Authors:  Frank Peters-Klimm; Stephen Campbell; Katja Hermann; Cornelia U Kunz; Thomas Müller-Tasch; Joachim Szecsenyi
Journal:  Trials       Date:  2010-05-17       Impact factor: 2.279

8.  Prognostic value of galectin-3, a novel marker of fibrosis, in patients with chronic heart failure: data from the DEAL-HF study.

Authors:  Dirk J A Lok; Peter Van Der Meer; Pieta W Bruggink-André de la Porte; Erik Lipsic; Jan Van Wijngaarden; Hans L Hillege; Dirk J van Veldhuisen
Journal:  Clin Res Cardiol       Date:  2010-02-04       Impact factor: 5.460

9.  Galectin-3 is an independent marker for ventricular remodeling and mortality in patients with chronic heart failure.

Authors:  Dirk J Lok; Sjoukje I Lok; Pieta W Bruggink-André de la Porte; Erik Badings; Eric Lipsic; Jan van Wijngaarden; Rudolf A de Boer; Dirk J van Veldhuisen; Peter van der Meer
Journal:  Clin Res Cardiol       Date:  2012-08-12       Impact factor: 5.460

10.  Primary care-based multifaceted, interdisciplinary medical educational intervention for patients with systolic heart failure: lessons learned from a cluster randomised controlled trial.

Authors:  Frank Peters-Klimm; Stephen Campbell; Thomas Müller-Tasch; Dieter Schellberg; Goetz Gelbrich; Wolfgang Herzog; Joachim Szecsenyi
Journal:  Trials       Date:  2009-08-13       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.